Man Group PLC Grifols Sa Transaction History

Man Group PLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$16.62 - $18.94 $15.9 Million - $18.1 Million	-954,222 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$16.86 - $19.67 $342,072 - $399,084	-20,289 Reduced 2.08%	954,222 $17.6 Million
Q3 2020 Nov 16, 2020	SELL	$15.4 - $20.16 $1.17 Million - $1.53 Million	-76,061 Reduced 7.24%	974,511 $16.9 Million
Q1 2020 May 15, 2020	SELL	$16.28 - $25.63 $13.4 Million - $21 Million	-821,203 Reduced 43.87%	1,050,572 $21.2 Million
Q4 2019 Feb 18, 2020	BUY	$19.57 - $23.52 $7.34 Million - $8.83 Million	375,261 Added 25.08%	1,871,775 $43.6 Million
Q3 2019 Nov 14, 2019	BUY	$19.85 - $22.76 $477,313 - $547,286	24,046 Added 1.63%	1,496,514 $30 Million
Q2 2019 Aug 14, 2019	BUY	$17.59 - $21.1 $351,747 - $421,936	19,997 Added 1.38%	1,472,468 $31.1 Million
Q1 2019 May 15, 2019	BUY	$18.01 - $20.11 $8.42 Million - $9.4 Million	467,645 Added 47.49%	1,452,471 $29.2 Million
Q4 2018 Feb 14, 2019	BUY	$17.44 - $21.53 $533,733 - $658,904	30,604 Added 3.21%	984,826 $18.1 Million
Q2 2018 Aug 14, 2018	BUY	$20.16 - $24.68 $19.2 Million - $23.6 Million	954,222 New	954,222 $20.5 Million

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.